Pharmacy-led reconciliation cuts readmissions in polypharmacy care
Australians are living longer with more chronic conditions, and that longevity brings a quiet complication. The typical patient over sixty-five takes five or more medicines daily. In Brisbane tertiary hospitals, polypharmacy is now the everyday workload, and the margin for medication error narrows at every transition.
Medication reconciliation verifies every drug a patient takes on admission, during transitions, and at discharge. When pharmacists lead the process, accuracy improves. The Australian Commission on Safety and Quality in Health Care has flagged it as a national priority, and Queensland Health services are embedding it within discharge workflows.
The model is straightforward in principle but demanding in execution. A pharmacist obtains the best possible medication history, flags discrepancies, and documents changes. For patients, it means a bedside conversation about supplements and adherence. For the system, fewer adverse drug events and fewer return journeys to hospital.
This piece examines how a pharmacy-led reconciliation programme changes outcomes for patients on complex regimens, what the local evidence says, and why the model deserves a permanent seat at the discharge planning table.
Why polypharmacy demands a coordinated response
Polypharmacy is not inherently harmful. For many older Queenslanders, multiple medicines represent careful, life-prolonging therapy. The problem arises when prescribers from different specialties add drugs without seeing the full picture, or when admission disrupts a regimen that was working well. Studies across Australian tertiary centres have found that more than half of patients experience at least one unintended discrepancy on admission.
Patients discharged on ten or more medicines face a substantially higher chance of thirty-day readmission than those on fewer than five. Bleeding from anticoagulants, hypoglycaemia, and renal impairment from stacked nephrotoxins are recurring themes in Queensland Health incident reports. Linguistic and cultural diversity adds another layer, particularly in suburbs such as Inala and Woodridge and in regional centres like Cairns.
A coordinated response treats the medication list as a living document. Pharmacists understand substitution, duplications, and dose adjustments in renal or hepatic impairment, and share language with community pharmacies on the other side of discharge. Bridging that gap is where reconciliation earns its keep.
How pharmacist-led reconciliation works at the bedside
The process begins within twenty-four hours of admission, when a pharmacist interviews the patient, contacts their community pharmacy, and reviews the GP record. My Health Record, where available, provides a national summary to check against what the patient actually takes, including complementary medicines.
During the stay, the pharmacist continues to review new prescriptions, adjusting for renal function, drug interactions, and guideline updates. At discharge, they reconcile the final list against admission history and in-hospital changes. The patient leaves with a written summary, a follow-up call within a week, and a Home Medicines Review appointment.
Core elements of an effective reconciliation process
- A verified best-possible medication history on admission
- Structured handover to the nominated community pharmacy at discharge
- Patient counselling in the patient's preferred language, including PBS cost considerations
- Follow-up contact within seven days of leaving hospital
The bedside element matters. A desk-only reconciliation misses pill burden, swallowing difficulties, and cost. When a pharmacist learns a patient cannot afford a brand-name combination product, they can suggest a PBS-listed alternative before discharge rather than after a preventable bounce-back.
Outcomes across Australian health services
Hospitals investing in structured pharmacist reconciliation consistently report lower thirty-day readmission rates for polypharmacy cohorts. The Royal Brisbane and Women's Hospital, along with services in Sydney and Melbourne, have published reductions of fifteen to thirty percent in unplanned returns. Each averted readmission saves the public system several thousand dollars, covering the salary of a reconciliation pharmacist.
Regional services face a different challenge. Distance from specialist centres means discharge summaries reach the GP late, and community pharmacies may have limited clinical information. Telehealth-enabled reconciliation, piloted in western Queensland, has shown promise. A hospital pharmacist conducts a video medication review before discharge, then sends a structured handover to the local provider.
Patient experience improves alongside the numbers. People report more confidence with their medicines, fewer missed doses, and a stronger relationship with their primary care team. For carers, the written plan reduces the anxiety that follows a complex stay.
Reconciliation versus conventional discharge at a glance
The contrast between pharmacist-led reconciliation and conventional discharge is best seen side by side. The differences span the entire patient journey, from the first hours of admission to the weeks that follow.
| Element | Pharmacist-led reconciliation | Conventional discharge |
|---|---|---|
| Medication history on admission | Verified by pharmacist against multiple sources | Often taken by junior medical officer |
| Discrepancy resolution | Documented and discussed with prescriber | Often left for community pharmacist to find |
| Patient counselling | Structured bedside session with written plan | Variable, often brief |
| Post-discharge follow-up | Phone call within seven days, GP review arranged | GP relies on discharge summary alone |
| Readmission rate for polypharmacy patients | Reduced 15–30% in published Australian cohorts | Higher, particularly within thirty days |
| Integration with PBS and community pharmacy | Active handover to nominated pharmacy | Passive referral |
The figures draw on published Australian cohort studies and reflect the experience of several metropolitan health services. They are consistent enough to suggest that the model itself, not the local setting, drives much of the improvement.
The differences are not theoretical. They translate directly into fewer adverse drug events, shorter hospital stays, and reduced pressure on emergency departments across Queensland.
Training and workforce considerations in Queensland
Embedding reconciliation into routine care requires more than goodwill. Queensland universities have expanded clinical pharmacy placements, and the Society of Hospital Pharmacists of Australia continues to advocate for credentialed roles within multidisciplinary teams. Rural placements through the Queensland Country Practice pathway help new graduates develop these skills outside metropolitan teaching hospitals.
Funding remains the perennial constraint. The Commonwealth Pharmacy Trial Programme has supported transitional care pilots, but permanent funding varies between services. Local data, aligned with the real-world data ethics, strengthens the case for sustained investment.
The workforce is evolving. Pharmacy technicians, under supervision, can complete the initial history, freeing senior pharmacists for complex reviews. This task-shifting model has worked well in Queensland Health transition programmes and offers a pragmatic answer to staffing pressure.
Ethics, data and the path forward
Every reconciliation generates data: what patients were taking, what they were prescribed, and what changed. Used well, that data sharpens prescribing and identifies system risks. Used poorly, it raises concerns about privacy and secondary use. Health services should align with national ethics frameworks and be transparent with patients about how their information contributes to research.
Digital integration is the next frontier. Linking hospital pharmacy systems with My Health Record, the PBS, and GP software would close the information gaps reconciliation currently fills by phone and fax. National electronic prescribing, now established across Australian community pharmacies, provides a foundation for built-in reconciliation workflows.
Priorities for sustainable implementation
- Permanent funding for pharmacist reconciliation roles in public hospitals
- Interoperable digital links between hospital, GP, and community pharmacy
- Routine patient-reported outcome measurement after discharge
- Clear governance for secondary use of reconciliation data
For patients and clinicians alike, the goal is simple: a medicine list that travels with the person, not one that fragments at every transition. Pharmacist-led reconciliation is the most reliable tool we have today for that goal.
For health services committed to translating evidence into better care across Queensland, Brisbane Diamantina Health Partners offers a collaborative platform where ideas, data, and expertise meet.
